Medical Device Patients and Magnetic Resonance Imaging
FDA Issues Draft Guidance with Updated Labeling and Testing Advice for the Use of Medical Devices in the Magnetic Resonance (MR) Environment UNITED STATES – As reported in an online article published by www.raps.org, the FDA released a draft guidance with updated advice to evaluate the safety and compatibility of medical devices … [Read more...] about Medical Device Patients and Magnetic Resonance Imaging
Injuries as a Result of Gadolinium Based Contrast Agent Injections Used During MRI Scans
FDA Request For The Addition Of Boxed Warnings About NSF. Parker Waichman LLP recently learned that the Federal Drug Administration (FDA) has notified healthcare professionals of the Agency’s request for the addition of boxed warnings and new warnings about the risk of Nephrogenic Systemic Fibrosis (NSF) for all Gadolinium based … [Read more...] about Injuries as a Result of Gadolinium Based Contrast Agent Injections Used During MRI Scans
